1. Home
  2. NLSP vs MKZR Comparison

NLSP vs MKZR Comparison

Compare NLSP & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • MKZR
  • Stock Information
  • Founded
  • NLSP 2015
  • MKZR 2012
  • Country
  • NLSP Switzerland
  • MKZR United States
  • Employees
  • NLSP N/A
  • MKZR N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • NLSP Health Care
  • MKZR
  • Exchange
  • NLSP Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • NLSP 12.4M
  • MKZR 10.3M
  • IPO Year
  • NLSP 2021
  • MKZR N/A
  • Fundamental
  • Price
  • NLSP $2.13
  • MKZR $0.65
  • Analyst Decision
  • NLSP
  • MKZR
  • Analyst Count
  • NLSP 0
  • MKZR 0
  • Target Price
  • NLSP N/A
  • MKZR N/A
  • AVG Volume (30 Days)
  • NLSP 268.4K
  • MKZR 66.6K
  • Earning Date
  • NLSP 07-22-2025
  • MKZR 08-11-2025
  • Dividend Yield
  • NLSP N/A
  • MKZR 52.85%
  • EPS Growth
  • NLSP N/A
  • MKZR N/A
  • EPS
  • NLSP N/A
  • MKZR N/A
  • Revenue
  • NLSP N/A
  • MKZR $23,037,348.00
  • Revenue This Year
  • NLSP N/A
  • MKZR N/A
  • Revenue Next Year
  • NLSP N/A
  • MKZR N/A
  • P/E Ratio
  • NLSP N/A
  • MKZR N/A
  • Revenue Growth
  • NLSP N/A
  • MKZR 52.64
  • 52 Week Low
  • NLSP $1.30
  • MKZR $0.60
  • 52 Week High
  • NLSP $15.59
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 43.58
  • MKZR N/A
  • Support Level
  • NLSP $2.20
  • MKZR N/A
  • Resistance Level
  • NLSP $2.33
  • MKZR N/A
  • Average True Range (ATR)
  • NLSP 0.25
  • MKZR 0.00
  • MACD
  • NLSP -0.07
  • MKZR 0.00
  • Stochastic Oscillator
  • NLSP 6.86
  • MKZR 0.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: